Federal contractor · DOYLESTOWN, PA

EVRYS BIO, INC.

No contract obligations recorded for EVRYS BIO, INC. in FY2026. Since FY2018: $150K. It also received $961.8K in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
TM98GAF3Z6Q6
Small businessWoman-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 150KFY2018
  2. 0FY2019
  3. 0FY2020

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for EVRYS BIO, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

EVRYS BIO, INC. received $961.8K in federal assistance in FY2026, on 2 actions (0 new awards), −49% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($961.8K).

Assistance · FY2026
$961.8K
New awards
0
Actions
2
Since FY2021
$7.1M

Assistance by fiscal year

  1. 1.3MFY2021
  2. 0FY2022
  3. 1MFY2023
  4. 2MFY2024
  5. 1.9MFY2025
  6. 961.8KFY2026

By type

  1. Grants$961.8K100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$961.8K100%

Awarding agencies

  1. National Institutes of Health$961.8K100%
    Department of Health and Human Services

Largest awards

  1. A SINGLE ANTIVIRAL TO TREAT MULTIPLE OPPORTUNISTIC INFECTIONS$6.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 21, 2021 – Aug 4, 2026· R44AI114079
  2. DEVELOPMENT OF A HOST-TARGETED ANTIVIRAL AS A CHRONIC HEPATITIS B THERAPEUTIC WITH POTENTIAL TO ACHIEVE A FUNCTIONAL CURE - FAST-TRACK…$3.2M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 20, 2021 – Sep 10, 2026· R44AI157725

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.